A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia
PspA and pneumolysin are two important vaccine candidates, able to elicit protection in different models of pneumococcal infection. The high immunogenic potential of PspA, combined with a possible adjuvant effect of pneumolysin derivatives (due to their ability to interact with TLR-4) could greatly...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728834/?tool=EBI |
| _version_ | 1811197988632002560 |
|---|---|
| author | Tanila Wood dos Santos Pedro Almeida Gonçalves Dunia Rodriguez José Aires Pereira Carlos Augusto Real Martinez Luciana C. C. Leite Lucio F. C. Ferraz Thiago Rojas Converso Michelle Darrieux |
| author_facet | Tanila Wood dos Santos Pedro Almeida Gonçalves Dunia Rodriguez José Aires Pereira Carlos Augusto Real Martinez Luciana C. C. Leite Lucio F. C. Ferraz Thiago Rojas Converso Michelle Darrieux |
| author_sort | Tanila Wood dos Santos |
| collection | DOAJ |
| description | PspA and pneumolysin are two important vaccine candidates, able to elicit protection in different models of pneumococcal infection. The high immunogenic potential of PspA, combined with a possible adjuvant effect of pneumolysin derivatives (due to their ability to interact with TLR-4) could greatly improve the immunogenicity and coverage of a protein-based pneumococcal vaccine. A chimeric protein including the N-terminal region of PspA in fusion with the pneumolysin derivative, PlD1, has been shown to induce high antibody levels against each protein, and protect mice against invasive challenge. The aim of the present study was to investigate the cellular response induced by such vaccine, and to evaluate protection in a murine model of lobar pneumococcal pneumonia. Pneumococcal pneumonia was induced in BALB/c mice by nasal instillation of a high dose of a serotype 14 strain with low virulence. Airway inflammation was confirmed by total and differential cell counts in BAL and by histological analysis of the lungs, and bacterial loads were measured 7 days after challenge. Cytokine levels were determined in the bronchoalveolar fluid (BALF) of mice immunized with rPspA-PlD1 fusion after challenge, by flow cytometry and ELISA. After challenge, the mice developed lung inflammation with no invasion of other sites, as demonstrated by histological analysis. We detected significant production of TNF-α and IL-6 in the BALF, which correlated with protection against pneumonia in the group immunized with rPspA-PlD1. In conclusion, we found that the rPspA-PlD1fusion is protective against pneumococcal pneumonia in mice, and protection is correlated with an early and controlled local inflammatory response. These results are in agreement with previous data demonstrating the efficacy of the fusion protein against pneumococcal sepsis and reinforce the potential of the rPspA-PlD1 protein chimera as a promising vaccine strategy to prevent pneumococcal disease. |
| first_indexed | 2024-04-12T01:23:37Z |
| format | Article |
| id | doaj.art-f02f6e51f01b4853b747a6f38a1f57a0 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T01:23:37Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-f02f6e51f01b4853b747a6f38a1f57a02022-12-22T03:53:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011712A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumoniaTanila Wood dos SantosPedro Almeida GonçalvesDunia RodriguezJosé Aires PereiraCarlos Augusto Real MartinezLuciana C. C. LeiteLucio F. C. FerrazThiago Rojas ConversoMichelle DarrieuxPspA and pneumolysin are two important vaccine candidates, able to elicit protection in different models of pneumococcal infection. The high immunogenic potential of PspA, combined with a possible adjuvant effect of pneumolysin derivatives (due to their ability to interact with TLR-4) could greatly improve the immunogenicity and coverage of a protein-based pneumococcal vaccine. A chimeric protein including the N-terminal region of PspA in fusion with the pneumolysin derivative, PlD1, has been shown to induce high antibody levels against each protein, and protect mice against invasive challenge. The aim of the present study was to investigate the cellular response induced by such vaccine, and to evaluate protection in a murine model of lobar pneumococcal pneumonia. Pneumococcal pneumonia was induced in BALB/c mice by nasal instillation of a high dose of a serotype 14 strain with low virulence. Airway inflammation was confirmed by total and differential cell counts in BAL and by histological analysis of the lungs, and bacterial loads were measured 7 days after challenge. Cytokine levels were determined in the bronchoalveolar fluid (BALF) of mice immunized with rPspA-PlD1 fusion after challenge, by flow cytometry and ELISA. After challenge, the mice developed lung inflammation with no invasion of other sites, as demonstrated by histological analysis. We detected significant production of TNF-α and IL-6 in the BALF, which correlated with protection against pneumonia in the group immunized with rPspA-PlD1. In conclusion, we found that the rPspA-PlD1fusion is protective against pneumococcal pneumonia in mice, and protection is correlated with an early and controlled local inflammatory response. These results are in agreement with previous data demonstrating the efficacy of the fusion protein against pneumococcal sepsis and reinforce the potential of the rPspA-PlD1 protein chimera as a promising vaccine strategy to prevent pneumococcal disease.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728834/?tool=EBI |
| spellingShingle | Tanila Wood dos Santos Pedro Almeida Gonçalves Dunia Rodriguez José Aires Pereira Carlos Augusto Real Martinez Luciana C. C. Leite Lucio F. C. Ferraz Thiago Rojas Converso Michelle Darrieux A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia PLoS ONE |
| title | A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| title_full | A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| title_fullStr | A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| title_full_unstemmed | A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| title_short | A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| title_sort | fusion protein comprising pneumococcal surface protein a and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728834/?tool=EBI |
| work_keys_str_mv | AT tanilawooddossantos afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT pedroalmeidagoncalves afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT duniarodriguez afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT joseairespereira afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT carlosaugustorealmartinez afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT lucianaccleite afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT luciofcferraz afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT thiagorojasconverso afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT michelledarrieux afusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT tanilawooddossantos fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT pedroalmeidagoncalves fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT duniarodriguez fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT joseairespereira fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT carlosaugustorealmartinez fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT lucianaccleite fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT luciofcferraz fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT thiagorojasconverso fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia AT michelledarrieux fusionproteincomprisingpneumococcalsurfaceproteinaandapneumolysinderivateconfersprotectioninamurinemodelofpneumococcalpneumonia |